Filing Details
- Accession Number:
- 0001645627-18-000073
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-27 17:04:13
- Reporting Period:
- 2018-11-20
- Accepted Time:
- 2018-11-27 17:04:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | No | No |
Transaction Summary
| Purchased: | 36,000 shares | Avg. Price: $0.03 | Total Value: $1,009.70 |
| Number of Shares After Transactions: | 26,197,498 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-11-20 | 1,000 | $0.03 | 26,162,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-20 | 1,000 | $0.03 | 26,163,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-20 | 1,000 | $0.03 | 26,164,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-20 | 1,000 | $0.03 | 26,165,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-20 | 2,000 | $0.03 | 26,167,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-20 | 1,000 | $0.03 | 26,168,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-20 | 1,000 | $0.03 | 26,169,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-20 | 1,000 | $0.03 | 26,170,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-20 | 1,000 | $0.03 | 26,171,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-20 | 1,000 | $0.03 | 26,172,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-20 | 1,000 | $0.03 | 26,173,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-20 | 1,000 | $0.03 | 26,174,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-20 | 1,000 | $0.03 | 26,175,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-21 | 1,000 | $0.03 | 26,176,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-21 | 2,000 | $0.03 | 26,178,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-21 | 3,000 | $0.03 | 26,181,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-21 | 1,000 | $0.03 | 26,182,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-21 | 2,000 | $0.03 | 26,184,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-21 | 2,000 | $0.03 | 26,186,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-21 | 1,000 | $0.03 | 26,187,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-21 | 1,000 | $0.03 | 26,188,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-21 | 1,000 | $0.03 | 26,189,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-21 | 1,000 | $0.03 | 26,190,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-21 | 1,000 | $0.03 | 26,191,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-21 | 1,000 | $0.03 | 26,192,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-21 | 1,000 | $0.03 | 26,193,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-21 | 1,000 | $0.03 | 26,194,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-21 | 1,000 | $0.03 | 26,195,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-21 | 1,000 | $0.03 | 26,196,498 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-21 | 1,000 | $0.03 | 26,197,498 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
